MedTrace Logo

The Relationship Between Neuropathic Complaints and Central Sensitization in Fibromyalgia

NCT05701696 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 111

Last updated 2023-02-28

No results posted yet for this study

Summary

Fibromyalgia (FM) is the prototype of a group of diseases known as central sensitivity syndromes, whose relationship with pain sensitization is well defined. Central sensitization (CS) is also one of the mechanisms involved in the pathophysiology of neuropathic pain. Neuropathic pain, which is a common complaint in FM patients, is likely to be one of the clinical manifestations of central sensitization. Therefore, in this study, it was aimed to investigate the relationship between CS and neuropathic pain.

Conditions

  • Central Sensitisation
  • Fibromyalgia
  • Neuropathic Pain

Interventions

DIAGNOSTIC_TEST

Central sensitization inventory

Standardized questionnaire to determine the level of central sensitization. Patients with a score of 40 and above are considered to have central sensitization.

DIAGNOSTIC_TEST

Widespread pain index

Total the number of painful body areas

DIAGNOSTIC_TEST

Symptom severity scale

The sum of the fatigue, waking unrefreshed and cognitive symptoms and the extent of somatic symptoms

OTHER

Fibromyalgia impact questionnaire

A tool to assess health status in fibromyalgia

DIAGNOSTIC_TEST

Hospital Anxiety and Depression Scale

An instrument for detecting depression and anxiety

DIAGNOSTIC_TEST

Self-Leeds Assessment of Neuropathic Symptoms and Signs

An instrument used to identify pain of neuropathic origin

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • Feyza Nur Yücel, MD · Saglik Bilimleri Universitesi

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-16
Primary Completion
2023-08-30
Completion
2023-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05701696 on ClinicalTrials.gov